Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The return on invested capital (ROIC) is N/A as of Tuesday, October 6, 2026.
RETURN ON INVESTED CAPITAL (ROIC)
N/A
Eocene Ltd.
Market Cap
$3.57M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.53M
Return on Invested Capital (ROIC)
-600.62%
TTM Avg
-217.41%
3Y Avg
-160.53%
5Y Avg
-160.53%
Market Cap
$3.64M
Return on Invested Capital (ROIC)
-9.04%
TTM Avg
-9.04%
3Y Avg
-6.72%
5Y Avg
4.87%
Market Cap
$3.49M
Return on Invested Capital (ROIC)
-45.77%
TTM Avg
-25.13%
3Y Avg
-754.36%
5Y Avg
-475.60%
Market Cap
$3.67M
Return on Invested Capital (ROIC)
-284.81%
TTM Avg
-319.42%
3Y Avg
-246.02%
5Y Avg
-246.02%
Market Cap
$3.46M
Return on Invested Capital (ROIC)
-33.50%
TTM Avg
-18.16%
3Y Avg
-45.78%
5Y Avg
-36.63%
Market Cap
$3.74M
Return on Invested Capital (ROIC)
-130.12%
TTM Avg
-72.08%
3Y Avg
-61.96%
5Y Avg
-55.38%
Market Cap
$3.75M
Return on Invested Capital (ROIC)
-346.94%
TTM Avg
-467.60%
3Y Avg
-296.93%
5Y Avg
-277.74%
Market Cap
$3.25M
Return on Invested Capital (ROIC)
-9.72%
TTM Avg
-8.51%
3Y Avg
-19.00%
5Y Avg
-22.23%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eocene Ltd. (EOCN) | $3.57M | N/A | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.53M | -600.62% | -217.41% | -160.53% | -160.53% |
| WORK Medical Technology Group Ltd. Class A (WOK)vs › | $3.64M | -9.04% | -9.04% | -6.72% | 4.87% |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -45.77% | -25.13% | -754.36% | -475.60% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.67M | -284.81% | -319.42% | -246.02% | -246.02% |
| Moolec Science S.A. (MLEC)vs › | $3.46M | -33.50% | -18.16% | -45.78% | -36.63% |
| Evogene Ltd. (EVGN)vs › | $3.74M | -130.12% | -72.08% | -61.96% | -55.38% |
| Ernexa Therapeutics Inc. (ERNA)vs › | $3.75M | -346.94% | -467.60% | -296.93% | -277.74% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.25M | -9.72% | -8.51% | -19.00% | -22.23% |
| 60 Degrees Pharmaceuticals, Inc. (SXTP)vs › | $3.90M | -321.28% | -227.99% | -186.65% | -145.51% |
ROIC
N/A
ROE
N/A
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
